A comparative study on the use of procalcitonin to distinguish between central fever and infectious causes of fever
- PMID: 38681106
- PMCID: PMC11055181
- DOI: 10.11604/pamj.2024.47.43.37617
A comparative study on the use of procalcitonin to distinguish between central fever and infectious causes of fever
Abstract
Introduction: central fever is defined as elevated body temperature without any evidence of infection or drug reaction fever, and currently it has no definitive diagnostic criteria. The current study aims to assess the role of procalcitonin (PCT) in differentiating central fever from fever secondary to infections in patients with neurological insults.
Methods: we conducted a retrospective study of patients admitted with a neurological insult (brain trauma, brain tumors and cerebrovascular accidents) in a tertiary care hospital. All patients who developed fever 48 hours after admission and had procalcitonin, C-reactive protein (CRP), and Erythrocyte sedimentation rate (ESR) done as part of fever evaluation were assessed to include in the study.
Results: out of 70 patients who met inclusion criteria, 37 had infections identified and 33 had no source of infection. The mean age was 42.9 years (± 18) in the infectious group while 40.3 years (± 18.2) in the central fever group and there was male predominance in both groups. In the infectious group there were 25(67.6%) males vs. 12(32.4%) females while in non -infectious group, males vs. females were 18(54.5%) vs. 15(45.5%) and there was no difference in both group (p-value 0.26) Median procalcitonin (PCT) value was 0.09 ng/dl (IQR 0.05- 0.19) in patients with no identified cause of infection and 1.4 ng/dl (IQR 0.5-5.1) in patients with infections with a p-value of <0.001. Although CRP and ESR were low in patients with central fever as compared to those with infections, these differences did not reach statistical significance with p-value of CRP 0.18 and p-value of ESR 0.31 between two groups.
Conclusion: PCT levels were low in patients with central fever and may be considered as a useful biomarker to differentiate between infectious fever from non-infectious fever in patients with brain injury. This can prevent unnecessary antibiotic use in patients without infection.
Keywords: Procalcitonin; central nervous system; fever; infections; stroke.
Copyright: Iffat Khanum et al.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.Blood Cells Mol Dis. 2020 Sep;84:102445. doi: 10.1016/j.bcmd.2020.102445. Epub 2020 May 14. Blood Cells Mol Dis. 2020. PMID: 32480243
-
Procalcitonin levels among patients with fever secondary to severe intracerebral infection. A cross-sectional study.Sao Paulo Med J. 2019 Oct 31;137(4):349-355. doi: 10.1590/1516-3180.2018.0458220719. eCollection 2019. Sao Paulo Med J. 2019. PMID: 31691767 Free PMC article.
-
Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.Cochrane Database Syst Rev. 2020 Sep 10;9(9):CD009185. doi: 10.1002/14651858.CD009185.pub3. Cochrane Database Syst Rev. 2020. PMID: 32911567 Free PMC article.
-
[Clinical significance of PCT, CRP, ESR, WBC count as predictors in postoperative early infectious complications with fever after posterior lumbar internal fixation].Zhongguo Gu Shang. 2015 Jan;28(1):66-70. Zhongguo Gu Shang. 2015. PMID: 25823137 Chinese.
-
The utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review.Lupus. 2022 Sep;31(10):1163-1174. doi: 10.1177/09612033221106157. Epub 2022 Jun 1. Lupus. 2022. PMID: 35650026
References
-
- Dimopoulos G, Falagas ME. Approach to the febrile patient in the ICU. Infect Dis Clin North Am. 2009;23(3):471–84. - PubMed
-
- Goyal K, Garg N, Bithal P. Central fever: a challenging clinical entity in neurocritical care. Journal of Neurocritical Care. 2020;13(1):19–31.
-
- Hocker SE, Tian L, Li G, Steckelberg JM, Mandrekar JN, Rabinstein AA. Indicators of central fever in the neurologic intensive care unit. JAMA Neuroly. 2013;70(12):1499–50. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous